close
MENU
Investment
5 mins to read

Cannasouth eyes 'meaningful revenue' in 2023

The NZX-listed medicinal cannabis company reported a deeper net loss in 2022, but believed it was about to turn a corner.

Cannasouth is in the process of merging with Bay of Plenty-based medicinal cannabis firm Eqalis.

Cannasouth believes 2023 is the year it starts generating “meaningful” revenue, with products in market and on the cusp of receiving crucial regulatory certification.

The medicinal cannabis firm has been, for the most part, a loss-making entity with low levels of income since it debuted on the

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Nicholas Pointon Thu, 02 Mar 2023
Contact the Writer: nicholas@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Company profile
Powered by: nzx logo
Change:
Price
Previous Close
Turnover
Movement
Volume
Avg Daily Volume
Daily High
Daily Low
52 Week High
52 Week Low
Cannasouth eyes 'meaningful revenue' in 2023
Investment,
98001
true